Abstract (EN):
Objective: To evaluate the impact of a medication follow-up program in patients with diabetes mellitus at a primary health care center, through the assessment of clinical and humanistic outcomes. Methods: Intervention study on a cohort of patients followed from October 2011 to July 2012. The family physician selected all the patients that went into the health care centre with a diagnosis of type 2 diabetes. A community pharmacist, who was transferred to the health care centre, made a medication follow-up to the patients that voluntarily agreed to participate in the study. Apart from the initial consultation, four more follow-up consultations were done. Socio-demographic data, life styles, medication and comorbidities, as well as biomarkers that enabled the evaluation of the patients' evolution were recorded. Results: Out of the 58 patients with diabetes in the health care centre, the 22 that agreed to participate in the study were 70.4 (SD=7.4) years old, and 54.4% were males. All the patients had hypertension and 59.1% hyperlipidemia. A total of 128 interventions were done, 75 (58.6%) of them were accepted and implemented by the physician. Significant differences (Willcoxon Signed Ranks tests) in A1c glycosylated hemoglobin (p=0.049), fasting blood glucose (p=0.007), systolic blood pressure (p=0.006), diabetes knowledge (Berbes questionnaire) (p=0.007) and satisfaction with the disease (DQOL satisfaction domain) (p=0.009) were obtained. Conclusion: A pharmacist who makes a medication follow-up in a health care centre and who is in close contact with a physician improves the majority of clinical and humanistic results in patients with diabetes.
Language:
Spanish
Type (Professor's evaluation):
Scientific